Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
7
×
national blog main
pfizer
biotech
clinical trials
new york blog main
new york top stories
boston blog main
boston top stories
breast cancer
national top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
amgen
gene therapy
glaxosmithkline
immunotherapy
national
new york
raleigh-durham blog main
raleigh-durham top stories
spark therapeutics
abbvie
acute migrane
adverum biotechnologies
akcea therapeutics
albert bourla
alzheimer's disease
american cancer society
amicus therapeutics
anylam pharmaceuticals
articles
artificial intelligence
arvinas
avelumab
bain capital
batten disease
bausch health
What
pfizer
7
×
drug
approved
bio
ceo
companies
company
past
patients
world’s
acquisitions
activity
ago
akcea
albert
alex
alnylam
amyloidosis
announced
argue
attr
available
based
battle
biggest
biontech
biotech
bourla
cancer
close
collaboration
combo
coming
covid
crispr
data
dating
days
debilitating
decade
Language
unset
unknown
Current search:
pfizer
×
" life sciences "
×
@techcrunch.com
2 years ago
BioNTech founder Uğur Şahin and Mayfield’s Ursheet Parikh are coming to Disrupt
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea